Ex parte LOWER - Page 7




          Appeal 1997-2575                                                             
          Application 08/524,661                                                       

                    10. With respect to the ketoximosilane (which Beers                
          calls an oxime), Beers states, inter alia (col. 5, lines 24-                 
          36):                                                                         
               The amount of the oxime curing agent ranges from about 2                
               to about 15 percent by weight with from about 4 to about                
               8 percent by weight being preferred based upon the total                
               weight of the composition.                                              
                                        *****                                          
               In order to insure that gellation or viscosity increases                
               do not occur, an excess of oxime crosslinking agents to                 
               silanol in the base polymer is utilized as an equivalent                
               ratio of from about 1.2 to about 4.0 with from about 1.5                
               to about 2.5 being preferred.                                           

                                   Beers Example 3                                     
                    11. Notwithstanding other portions of the                          
          description of the Beer invention, Example 3 describes a                     
          silicone sealant having "excellent low modulus properties"                   
          (col. 9, line 8) said to have been made with a calcium                       
          carbonate filler having 0.4% [applicant claims greater than                  
          0.25%] water.  The amount of filler in the composition is said               


                                        - 7 -                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007